These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 3608214)

  • 1. Female carriers of Duchenne muscular dystrophy: a dilemma.
    Isaacs H; Badenhorst M
    Clin Genet; 1987 May; 31(5):288-96. PubMed ID: 3608214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Failure of inactivation of Duchenne dystrophy X-chromosome in one of female identical twins.
    Gomez MR; Engel AG; Dewald G; Peterson HA
    Neurology; 1977 Jun; 27(6):537-41. PubMed ID: 559260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Estimation of the probability of heterozygosity in Duchenne-type progressive muscular dystrophy].
    Guízar Vázquez J; Navarrete Cadena C; Rico R; Mora G; Zavala C
    Bol Med Hosp Infant Mex; 1981; 38(1):23-33. PubMed ID: 7284070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Duchenne muscular dystrophy manifesting carriers.
    Barkhaus PE; Gilchrist JM
    Arch Neurol; 1989 Jun; 46(6):673-5. PubMed ID: 2730379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diminished cap formation in lymphocytes from patients and carriers of Duchenne muscular dystrophy.
    Verrill HL; Pickard NA; Gruemer HD
    Clin Chem; 1977 Dec; 23(12):2341-3. PubMed ID: 923085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The manifesting carrier in Duchenne muscular dystrophy.
    Moser H; Emery AE
    Clin Genet; 1974; 5(4):271-84. PubMed ID: 4854942
    [No Abstract]   [Full Text] [Related]  

  • 7. Monozygotic female twin carriers discordant for the clinical manifestations of Duchenne muscular dystrophy.
    Chutkow JG; Hyser CL; Edwards JA; Heffner RR; Czyrny JJ
    Neurology; 1987 Jul; 37(7):1147-51. PubMed ID: 2885783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of correlation between skewed X inactivation in blood and serum creatine-kinase levels in Duchenne/Becker female carriers.
    Sumita DR; Vainzof M; Campiotto S; Cerqueira AM; Cánovas M; Otto PA; Passos-Bueno MR; Zatz M
    Am J Med Genet; 1998 Dec; 80(4):356-61. PubMed ID: 9856563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. X-linked Duchenne muscular dystrophy in an unusual family with manifesting carriers.
    Kaladhar Reddy B; Anandavalli TE; Reddi OS
    Hum Genet; 1984; 67(4):460-2. PubMed ID: 6490012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The fluctuation of serum myoglobin levels in Duchenne muscular dystrophy and the carrier.
    Konagaya M; Takayanagi T; Konagaya Y; Sobue I
    J Neurol Sci; 1982 Sep; 55(3):259-65. PubMed ID: 6890096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum alpha-galactosidase activity in children with Duchenne-type muscular dystrophy and in gene carriers.
    László A; Havass Z
    Acta Paediatr Hung; 1983; 24(4):327-9. PubMed ID: 6324830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Duchenne muscular dystrophy carrier presenting with mosaic X chromosome constitution and muscular symptoms--with analysis of the barr bodies in the muscle].
    Kinoshita M; Ikeda K; Yoshimura M; Saku A; Watanabe K
    Rinsho Shinkeigaku; 1990 Jun; 30(6):643-6. PubMed ID: 2225660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muscular dystrophy. Part II: Serum enzymes in relatives of cases of the Duchenne muscular dystrophy.
    Narayanan I; Ramakrishna Rao P; Balakrishnan S; Subrahmanyam K
    Indian J Med Res; 1974 Apr; 62(4):605-11. PubMed ID: 4435869
    [No Abstract]   [Full Text] [Related]  

  • 14. Genetic and environmental components of serum creatine kinase (CK) and pyruvate kinase (PK) in normal twins: implication for genetic risks estimates in Duchenne muscular dystrophy carriers.
    Rapaport D; Colletto GM; Zatz M
    Am J Med Genet; 1988 Oct; 31(2):291-8. PubMed ID: 3232697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duchenne muscular dystrophy in Tunisia: a clinical and morphological study of 77 cases.
    Ben Hamida M; Miladi N; Turki I; Zaiem H
    J Neurol Sci; 1992 Jan; 107(1):60-4. PubMed ID: 1578235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Symptomatic carriers of muscular dystrophy.
    Azam M
    J Pak Med Assoc; 1997 Mar; 47(3):89-93. PubMed ID: 9131861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinico-epidemiologic study of Duchenne muscular dystrophy].
    Giacanelli M; Gneo S; Liguori M; Tarsitani G; Tessarolo D
    Nuovi Ann Ig Microbiol; 1988; 39(2):129-35. PubMed ID: 3244530
    [No Abstract]   [Full Text] [Related]  

  • 18. [Echoscopic diagnosis of the heterozygote carrier state in Duchenne's muscular dystrophy].
    Krasil'nikov VV; Lazebnik TA; Prokof'ev GV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(11):18-9. PubMed ID: 3066080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Xp21/autosome translocations. Case report and risk for Duchenne muscular dystrophy.
    Holden JJ; Smith A; MacLeod PM; Masotti R; Duncan AM
    Clin Genet; 1986 Jun; 29(6):516-22. PubMed ID: 3742857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Letter: Follow-up study of serum-creatine-kinase in carriers of Duchenne muscular dystrophy.
    Moser H; Vogt J
    Lancet; 1974 Sep; 2(7881):661-2. PubMed ID: 4137773
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.